Table 2.
Characteristics of prostate cancer patients
| Characteristics | |
|---|---|
| Age at diagnosis (years), range (median) | 59–88 (73) |
| Metastasis at diagnosis | |
| Negative | 17 |
| Positive | 26 |
| Biopsy Gleason score | |
| GS ≤6 | 4 |
| GS 7 | 5 |
| GS 8–10 | 31 |
| iPSA (ng/mL), range (median) | 5.3–9,529 (130) |
| Sensitivity to castration | |
| CSPC | 20 |
| CRPC | 23 |
| Duration of hormonal T (years), range (median) | 0.0–14.1 (2.5) |
| Clinical recurrence | |
| Negative | 35 |
| Positive | 8 |
| Previous docetaxel T | |
| Negative | 37 |
| Positive | 6 |
Notes: Gleason score is missing for three patients, as pathologist did not report it.
Abbreviations: iPSA, initial prostate-specific antigen; CSPC, castration-sensitive prostate cancer; CRPC, castration-resistant prostate cancer; T, therapy.